Genmab

28. April 2024

DGAP-Adhoc: Genmab Unveils A New Antibody Technology Platform: HexaBody | Dow Jones News auf 4investors.de

17.12.2012 –

DJ DGAP-Adhoc: Genmab Unveils A New Antibody Technology Platform: HexaBody

Genmab A/S

17.12.2012 08:28

Dissemination of a Adhoc News, transmitted by DGAP – a company of
EquityStory AG.
The issuer is solely responsible for the content of this announcement.

=————————————————————————–

Company Announcement

— HexaBody Quelle: 4investors… [weiterlesen]

DGAP-Adhoc: Genmab Reduces Fair Value of Minnesota Manufacturing Facility to Zero, Moves Sale into 2013 and Updates 2012 Gui | Dow Jones News auf 4investors.de

13.12.2012 –

DJ DGAP-Adhoc: Genmab Reduces Fair Value of Minnesota Manufacturing Facility to Zero, Moves Sale into 2013 and Updates 2012 Guidance

Genmab A/S

13.12.2012 17:56

Dissemination of a Adhoc News, transmitted by DGAP – a company of
EquityStory AG.
The issuer is solely responsible for the content of this announcement.

=————————————————————————– Quelle: 4investors… [weiterlesen]

DGAP-Adhoc: New Preliminary Efficacy Data for Daratumumab Presented at ASH | Dow Jones News auf 4investors.de

09.12.2012 –

DJ DGAP-Adhoc: New Preliminary Efficacy Data for Daratumumab Presented at ASH

Genmab A/S

09.12.2012 18:01

Dissemination of a Adhoc News, transmitted by DGAP – a company of
EquityStory AG.
The issuer is solely responsible for the content of this announcement.

=————————————————————————–

Company Announcement

— Preliminary Quelle: 4investors… [weiterlesen]

DGAP-Adhoc: Genmab Announces DuoBody Platform Collaboration with Kyowa Hakko Kirin | Dow Jones News auf 4investors.de

05.12.2012 –

DJ DGAP-Adhoc: Genmab Announces DuoBody Platform Collaboration with Kyowa Hakko Kirin

Genmab A/S

05.12.2012 07:51

Dissemination of a Adhoc News, transmitted by DGAP – a company of
EquityStory AG.
The issuer is solely responsible for the content of this announcement.

=————————————————————————–

Company Announcement

- Quelle: 4investors… [weiterlesen]

DGAP-Adhoc: Agreement for Daratumumab Receives Antitrust Clearance | Dow Jones News auf 4investors.de

21.09.2012 –

DJ DGAP-Adhoc: Agreement for Daratumumab Receives Antitrust Clearance

Genmab A/S

21.09.2012 18:01

Dissemination of a Adhoc News, transmitted by DGAP – a company of
EquityStory AG.
The issuer is solely responsible for the content of this announcement.

=————————————————————————–

Company Announcement

— Daratumumab Quelle: 4investors… [weiterlesen]